Over the past 2 years, Zika virus (ZIKV) has emerged as a pathogen capable of causing devastating congenital malformations in the developing fetus and significant neurological disease in adults. In 2017, substantial progress has been made towards the development, immunological analysis and preclinical evaluation of vaccine platforms to prevent the pathologies associated with ZIKV infection.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
A yellow fever–Zika chimeric virus vaccine candidate protects against Zika infection and congenital malformations in mice
npj Vaccines Open Access 13 December 2018
-
Process intensification of EB66® cell cultivations leads to high-yield yellow fever and Zika virus production
Applied Microbiology and Biotechnology Open Access 08 August 2018
-
Rational Zika vaccine design via the modulation of antigen membrane anchors in chimpanzee adenoviral vectors
Nature Communications Open Access 22 June 2018
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Abbink, P. et al. Protective efficacy of multiple vaccine platforms against Zika virus challenge in rhesus monkeys. Science 353, 1129–1132 (2016).
Larocca, R. A. et al. Vaccine protection against Zika virus from Brazil. Nature 536, 474–478 (2016).
Dowd, K. A. et al. Rapid development of a DNA vaccine for Zika virus. Science 354, 237–240 (2016).
Pardi, N. et al. Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination. Nature 543, 248–251 (2017).
Richner, J. M. et al. Modified mRNA vaccines protect against Zika virus infection. Cell 168, 1114–1125. e10 (2017).
George, J. et al. Prior exposure to Zika virus significantly enhances peak Dengue-2 viremia in rhesus macaques. Sci. Rep. 7, 10498 (2017).
Richner, J. M. et al. Vaccine mediated protection against Zika virus-induced congenital disease. Cell 170, 273–283. e12 (2017).
Shan, C. et al. A live-attenuated Zika virus vaccine candidate induces sterilizing immunity in mouse models. Nat. Med. 23, 763–767 (2017).
Shan, C. et al. A single-dose live-attenuated vaccine prevents Zika virus infection, pregnancy transmission, and testis damage. Nat. Commun. 8, 676 (2017).
Elong Ngono, A. et al. Mapping and role of the CD8+ T cell response during primary Zika virus infection in mice. Cell Host Microbe 21, 35–46 (2017).
Wen, J. et al. Identification of Zika virus epitopes reveals immunodominant and protective roles for dengue virus cross-reactive CD8+ T cells. Nat. Microbiol. 2, 17036 (2017).
Author information
Authors and Affiliations
Contributions
M.S.D and C.B.C. wrote the article. Both authors reviewed and edited the manuscript before submission.
Corresponding authors
Ethics declarations
Competing interests
M.S.D. is a consultant for Aviana, Inbios, Sanofi-Pasteur and Takeda and is on the scientific advisory boards of Moderna and OvaGene.
PowerPoint slides
Rights and permissions
About this article
Cite this article
Diamond, M., Coyne, C. Closing in on a Zika virus vaccine. Nat Rev Immunol 18, 89–90 (2018). https://doi.org/10.1038/nri.2017.132
Published:
Issue Date:
DOI: https://doi.org/10.1038/nri.2017.132
This article is cited by
-
A yellow fever–Zika chimeric virus vaccine candidate protects against Zika infection and congenital malformations in mice
npj Vaccines (2018)
-
Process intensification of EB66® cell cultivations leads to high-yield yellow fever and Zika virus production
Applied Microbiology and Biotechnology (2018)
-
Rational Zika vaccine design via the modulation of antigen membrane anchors in chimpanzee adenoviral vectors
Nature Communications (2018)